Dana-Farber Cancer Institute
MiryamYusufov
The purpose of this research study is to develop a psychological treatment for patients with cancer, focused on the psychological symptoms they experience during opioid therapy.
Cancer
Acceptance & Commitment Therapy
This research study is a treatment development study, which is the first time investigators are developing this psychological intervention in patients with cancer, on opioid therapy. This study is being conducted to develop a psychological intervention designed specifically for individuals with cancer. The purpose of this study is to determine how practical this intervention is, to determine patient satisfaction, and test the study procedures.}}
Study Type : | Observational |
Estimated Enrollment : | 10 participants |
Official Title : | Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain |
Actual Study Start Date : | February 20, 2019 |
Estimated Primary Completion Date : | June 30, 2021 |
Estimated Study Completion Date : | July 30, 2021 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115